NK
Narender Kumar
Homi Bhabha Cancer Hospital & Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Shri Mahant Indresh Hospital, University of Campania Luigi Vanvitelli, Harvard Medical School
Employment
-
Homi Bhabha Cancer Hospital & Mahamana Pandit Madan Mohan Malaviya Cancer Centre2025 - Present
-
Shri Mahant Indresh Hospital2021 - 2024
-
Institute for Experimental Endocrinology and Oncology Early Stage Researcher2016 - 2019
-
All India Institute of Medical Sciences - Rishikesh Junior Resident Doctor2016 - 2016
-
Delhi State Cancer Institute Junior Resident Doctor2015 - 2015
Education
-
University of Campania Luigi Vanvitelli PhD2016 - 2019
-
Harvard Medical School Global Clinical Scholars Research Trainig2016 - 2017
-
Sardar Patel Medical College MBBS2009 - 2015
Projects & Funding
Projects & funding information is unavailable.
Publications (23)
- A National Perspective on the Impact of the COVID-19 Pandemic on Heart Failure Hospitalizations in the United States. Save
- PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells. Save
- Lymph node staging systems in oral squamous cell carcinoma: A comparative analysis. Save
- Concurrent chemoradiotherapy for head and neck cancers in older patients: Outcomes and their determinants. Save
- Predictors of locoregional control in stage I/II oral squamous cell carcinoma classified by AJCC 8th edition. Save
- Neurofibromatosis with chronic myeloid leukemia in an elderly male: An unusual association Save
- Detection of bone metastasis in nasopharyngeal carcinoma by bone scintigraphy: A retrospective study in perspective of limited resource settings Save
- Analysis of bone metastasis in head and neck squamous cell carcinoma: Experience of a regional cancer center Save
- 125PA PROSPECTIVE RANDOMIZED PHASE III STUDY OF PALLIATIVE CHEMOTHERAPY VERSUS BEST SUPPORTIVE CARE IN ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER: SURVIVAL ANALYSIS AND ECOG PERFORMANCE STATUS REGRESSION ANALYSIS Save
- 10PALLELE FREQUENCY OF ABO AND RH BLOOD GROUP AND THE RISK OF NON SMALL CELL LUNG CARCINOMA Save